Usrc Altus is a medicare approved dialysis facility center in Altus, Oklahoma and it has 13 dialysis stations. It is located in Jackson county at 1401 E Broadway, Altus, OK, 73522. You can reach out to the office of Usrc Altus at (580) 480-0170. This dialysis clinic is managed and/or owned by Diversified Specialty Institutes (dsi). Usrc Altus has the following ownership type - Profit. It was first certified by medicare in September, 2014. The medicare id for this facility is 372598 and it accepts patients under medicare ESRD program.
Dialysis Center Profile
| Name | Usrc Altus |
|---|
| Location | 1401 E Broadway, Altus, Oklahoma |
|---|
| No. of Dialysis Stations | 13 |
|---|
| Medicare ID | 372598 |
|---|
| Managed By | Diversified Specialty Institutes (dsi) |
|---|
| Ownership Type | Profit |
|---|
| Late Shifts | No |
|---|
Services Offered
- Hemodialysis
- Peritoneal Dialysis
Patient Distribution
Anemia Management
| Dialysis patients with Hemoglobin data | 21 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 43 |
Dialysis Adequacy
For adult patients on hemodialysis, Kt/V should be at least 1.2 and for peritoneal dialysis at least 1.7; that means they are receiving the right amount of dialysis. For pediatric patients, Kt/V should be at least 1.2 on hemodialysis and 1.8 on peritoneal dialysis.
Higher percentages are better.
- Hemodialysis
| Adult patients getting regular hemodialysis at the center | 51 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 474 |
| Percentage of adult hemodialysis patients with Kt/V greater than or equal to 1.2 | 97 |
Mineral and Bone Disorder
An important goal of dialysis is to maintain normal levels of various minerals
in the body, such as calcium. This shows the percentage of patients
treated at Usrc Altus with elevated calcium levels.
| Patients in the hypercalcemia summary | 53 |
| Hypercalcemia patient months | 492 |
| Percentage of adult patients with serum calcium greater than 10.2 mg/dL | 1 |
| Patients in the serum phosphorus summary | 56 |
| Percentage of patients with serum phosphorus less than 3.5 mg/dL | 14 |
| Percentage of patients with serum phosphorus from 3.5 to 4.5 mg/dL | 22 |
| Percentage of patients with serum phosphorus from 4.6 to 5.5 mg/dL | 26 |
| Percentage of patients with serum phosphorus from 5.6 to 7 mg/dL | 24 |
| Percentage of patients with serum phosphorus greater than 7 mg/dL | 15 |
Vascular Access
The arteriovenous (AV) fistula is considered the best long-term vascular access for hemodialysis because it
allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access.
Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arteriovenous fistula and catheter summaries | 55 |
| Patient months included in arteriovenous fistula and catheter summaries | 518 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistula for their treatment | 77.9 |
| Percentage of patients receiving treatment through a vascular catheter for 90 days or longer | 13 |
Hospitalization Rate
The rate of hospitalization shows you whether patients who were being treated regularly at Usrc Altus were admitted to the
hospital more often (worse than expected), less often (better than expected), or about the same (as expected),
compared to similar patients treated at other centers.
| Standardized Hospitalization Ratio (SHR) Period | January, 2024 - December, 2024 |
| Patients in facility's Hospitalization Summary | 55 |
| Hospitalization Rate in facility | 131 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 223.7 |
| Hospitalization Rate: Lower Confidence Limit | 82.4 |
Readmission Rate
The rate of readmission shows you whether patients who were being treated regularly at Usrc Altus
were readmitted more often (worse than expected), less often (better than expected), or
about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standardized Readmission Ratio (SRR) Period | January, 2024 - December, 2024 |
| Readmission Rate in facility | 21.7 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 38.9 |
| Readmission Rate: Lower Confidence Limit | 9.7 |
Infection Rate
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to
enter the body and cause infection. This information shows how often patients at Usrc Altus get infections in their blood each year
compared to the number of infections expected for the center based on the national average.
| Standardized Infection Ratio (SIR) Period | January, 2024 - December, 2024 |
| Infection Ratio in facility | 0.28 (As Expected) |
| SIR: Upper Confidence Limit | 1.41 |
| SIR: Lower Confidence Limit | 0.01 |
Transfusion Summary
Patients with anemia require blood transfusions if their anemia is not managed well by their
dialysis center. This information shows whether Usrc Altus's rate of transfusions is better than expected,
as expected, or worse than expected, compared to other centers that treat similar patients.
| Standardized Transfusion Ratio (STrR) Period | January, 2024 - December, 2024 |
| Patients in facility's Transfusion Summary | 36 |
| Transfusion Rate in facility | 33.6 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 94.8 |
| Transfusion Rate: Lower Confidence Limit | 15.3 |
Survival Summary
The rate of mortality shows you whether patients who were being treated regularly at Usrc Altus lived longer than
expected (better than expected), did not live as long as expected (worse than expected), or lived as long as expected (as expected), compared
to similar patients treated at other facilities.
| Standardized Mortality Ratio (SMR) Period | January, 2021 - December, 2024 |
| Patients in facility's Survival Summary | 202 |
| Mortality Rate in facility | 27.9 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 42.3 |
| Mortality Rate: Lower Confidence Limit | 18.4 |